Unsere Forschungstätigkeit
Das Freiburger Brustzentrum beteiligt sich aktiv an internationalen klinischen Studien sowie der Entwicklung von innovativen Medikamenten und neuen Technologien, um Krebs zu heilen. Die Ärztinnen und Ärzte können ihrer Patientin vorschlagen, im Rahmen der Forschung an einer klinischen Studie teilzunehmen.
Laufende Studien
TAXIS
Interventionell
Tailored Axillary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS). A multicenter randomized phase III trial
CASCADE/DIALOGUE
Nicht-Interventionell
Cascade Genetic Testing for Hereditary Breast Ovarian Cancer and Lynch Syndrome in Switzerland
PREcoopERA
Interventionell
«A Window-of Opportunity trial of giredestrant +/- triptorelin vs. Anastrozol + triptorelin in premenopausal patients with ER-positive/HER2- negative early breast cancer »
DESTINY
Nicht-Interventionell
A prospective, non-interventional study (NIS) with trastuzumab deruxtecan for patients with HER2-low expressing unresecable and/or metastatic breast cancer accompanied by a disease registry of patients treated with conventional chemotherapy
MSD
MK 2870-012
Interventionell
A phase 3, randomized, open-label, study to compare the efficacy and safety of Adjuvant MK-2870 in combination with Pembrolizumab (MK-3475) versus treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and not achieve a pathological complete response (pCR) at surgery